These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27529587)

  • 1. Step by step, the description of the "biodegradable" strategy for the treatment of coronary bifurcation lesions.
    Piraino D; Cimino G; Andolina G
    Int J Cardiol; 2016 Nov; 223():37-39. PubMed ID: 27529587
    [No Abstract]   [Full Text] [Related]  

  • 2. Treading the risky ground of coronary bifurcation lesion revascularization, the "biodegradable strategy" may represent the lifeline.
    Piraino D; Buccheri D; Andolina G
    Int J Cardiol; 2016 Oct; 221():577-80. PubMed ID: 27420582
    [No Abstract]   [Full Text] [Related]  

  • 3. Side branch occlusion after bioresorbable vascular scaffold implantation: lessons from optimal coherence tomography.
    Sato K; Panoulas VF; Kawamoto H; Naganuma T; Miyazaki T; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):116-8. PubMed ID: 25616826
    [No Abstract]   [Full Text] [Related]  

  • 4. 1-year follow-up optical coherence tomography of a "hybrid" neocarina after T-stenting with small protrusion technique using a bioresorbable vascular scaffold and a metallic stent.
    Naganuma T; Panoulas VF; Latib A; Kawamoto H; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2015 May; 8(6):e101-e103. PubMed ID: 25912406
    [No Abstract]   [Full Text] [Related]  

  • 5. Twenty-four months of follow-up of a "biodegradable" model for coronary artery bifurcation management. Insights from optical coherence tomography of a new interventional strategy.
    Buccheri D; Cortese B
    Int J Cardiol; 2016 Nov; 222():37-38. PubMed ID: 27448703
    [No Abstract]   [Full Text] [Related]  

  • 6. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.
    Mattesini A; Secco GG; Dall'Ara G; Ghione M; Rama-Merchan JC; Lupi A; Viceconte N; Lindsay AC; De Silva R; Foin N; Naganuma T; Valente S; Colombo A; Di Mario C
    JACC Cardiovasc Interv; 2014 Jul; 7(7):741-50. PubMed ID: 25060016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe Neointimal Hyperplasia of Neoplastic Carina Following Bioresorbable Scaffold Implantation Using T-Stenting and Small Protrusion Technique: Insights From Optical Frequency Domain Imaging.
    Kawamoto H; Ruparelia N; Figini F; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Nov; 8(13):e207-9. PubMed ID: 26476605
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migrated remnant bioresorbable scaffolds in a left main bifurcation lesion: Insights from optical coherence tomography.
    Seo J; Kim Y; Kim BK; Hong SJ; Ahn CM; Kim JS; Cho DK; Ko YG; Choi D; Hong MK; Jang Y
    Cardiol J; 2020; 27(2):208-209. PubMed ID: 32463107
    [No Abstract]   [Full Text] [Related]  

  • 10. First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.
    Latini RA; Buccheri D; Cortese B
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):676-678. PubMed ID: 27649683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical coherence tomography of a bifurcation lesion treated with bioresorbable vascular scaffolds with the "mini-crush" technique.
    Costopoulos C; Naganuma T; Latib A; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1326-7. PubMed ID: 24355123
    [No Abstract]   [Full Text] [Related]  

  • 12. Bifurcation lesions: Bioresorbable vascular scaffold and drug coated balloon, an efficacy association. Lessons from optimal coherence tomography.
    Piraino D; Carella M; Buccheri D; Andolina G
    Int J Cardiol; 2016 Jun; 212():92-3. PubMed ID: 27038711
    [No Abstract]   [Full Text] [Related]  

  • 13. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
    Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM
    Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unfavorable bioresorbable vascular scaffold resorption, a cause of restenosis?
    Ishida K; Giacchi G; Brugaletta S; García-Álvarez A; Sabaté M
    Cardiovasc Revasc Med; 2016 Dec; 17(8):571-573. PubMed ID: 27345841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary bifurcation lesions: Some questions need an answer to make bioresorbable vascular scaffold technology more "coronary bifurcation-friendly".
    Piraino D; Buccheri D; Andolina G
    Int J Cardiol; 2016 Jul; 215():80-3. PubMed ID: 27111164
    [No Abstract]   [Full Text] [Related]  

  • 16. Revascularization treatment for spontaneous coronary artery dissection: A reconsideration of drug-coated balloons and bioresorbable vascular scaffold.
    Wu S; Liu W; Zhao Y; Shi D; Liu R; Wang J; Yu Y; Jia S; Sun Y; Zhou Y
    Int J Cardiol; 2016 Apr; 209():49-50. PubMed ID: 26878475
    [No Abstract]   [Full Text] [Related]  

  • 17. Two-Year Follow-Up OCT Images of 2 Bifurcation Lesions Treated With Bioresorbable Vascular Scaffolds.
    Kawamoto H; Panoulas VF; Sato K; Miyazaki T; Latib A; Colombo A
    JACC Cardiovasc Imaging; 2015 May; 8(5):617-618. PubMed ID: 25457765
    [No Abstract]   [Full Text] [Related]  

  • 18. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
    Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
    [No Abstract]   [Full Text] [Related]  

  • 19. Early Collapse of a Magnesium Bioresorbable Scaffold.
    Cubero-Gallego H; Vandeloo B; Gomez-Lara J; Romaguera R; Roura G; Gomez-Hospital JA; Cequier A
    JACC Cardiovasc Interv; 2017 Sep; 10(18):e171-e172. PubMed ID: 28935085
    [No Abstract]   [Full Text] [Related]  

  • 20. The Absorb Limits.
    Gómez Menchero AE; Camacho Freire SJ; Díaz Fernández JF; Roa Garrido J; León Jiménez J; Cardenal Piris R
    J Invasive Cardiol; 2016 Oct; 28(10):E122-E123. PubMed ID: 27705895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.